Meproten en es it fr

Meproten Brand names, Meproten Analogs

Meproten Brand Names Mixture

  • No information avaliable

Meproten Chemical_Formula


Meproten RX_link

No information avaliable

Meproten fda sheet

Meproten msds (material safety sheet)

Meproten Synthesis Reference

No information avaliable

Meproten Molecular Weight

309.469 g/mol

Meproten Melting Point

< 25 oC

Meproten H2O Solubility

Soluble as HCl salt

Meproten State


Meproten LogP


Meproten Dosage Forms

Tablets (oral, 1 mg)

Meproten Indication

Used for the symptomatic treatment of parkinsonism.

Meproten Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meproten Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meproten side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meproten Patient Information

Meproten Organisms Affected

Humans and other mammals